Intro

This chapter explores Vertex Pharmaceuticals' unique strategies in developing treatments for complex diseases alongside insights from Charles Schwab's latest earnings report. The discussion highlights advancements in the healthcare sector and significant shifts in the financial landscape, revealed during a live event in San Francisco.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app